WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |

Search International and National Patent Collections
World Intellectual Property Organization
Machine translation
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/093406    International Application No.:    PCT/IN2012/000005
Publication Date: 12.07.2012 International Filing Date: 03.01.2012
A61K 39/04 (2006.01), A61K 39/08 (2006.01), A61K 39/10 (2006.01), A61K 39/102 (2006.01), A61K 39/13 (2006.01), A61K 39/15 (2006.01), A61K 39/29 (2006.01)
Applicants: BHARAT BIOTECH INTERNATIONAL LIMITED [IN/IN]; Genome Valley, Turkapally, Shameerpet, Hyderabad 500 078 (IN) (For All Designated States Except US).
KUPPUSWAMY, Gopinathan [IN/IN]; (IN) (For US Only).
THIAGARAJAN, Vijayanand [IN/IN]; (IN) (For US Only)
Inventors: KUPPUSWAMY, Gopinathan; (IN).
THIAGARAJAN, Vijayanand; (IN)
Agent: HASAN, Afzal; Hasan And Singh Flat No. 1-A, C. O. D. Staff Apartment (Near ING Vyasa Bank), Cyberabad Post Madhapur, Hyderabad 500081 (IN)
Priority Data:
27/CHE/2011 05.01.2011 IN
Abstract: front page image
(EN)The invention provides a stable immunogenic composition for prevention and prophylaxis of infections caused by rota virus, poliomyelitis virus, Haemophilius influenza, Hepatitis B, Corynebacterium diphtheriae, Clostridium tetani, Bordatella pertusis (acellular) in a single combined vaccine. The invention also provides for a bivalent immunogenic composition against rota virus and polio virus. The process of making such compositions of the multivalent antigens are also disclosed. The present invention also relates to the production and use of such vaccines for prophylaxis against the infections mentioned above
(FR)L'invention concerne une composition immunogène stable de prévention et de prophylaxie d'infections causées par le rotavirus, la poliomyélite, le bacille de Pfeiffer, l'hépatite B, la diphtérie, le bacille tétanique, la coqueluche (acellulaire) dans un vaccin combiné unique. L'invention concerne également une composition immunogène bivalente contre le rotavirus et la poliomyélite. Le procédé de préparation de ces compositions d'antigènes multivalents est également décrit. Cette invention concerne enfin la production et l'utilisation de ces vaccins dans la prophylaxie contre les infections susmentionnées.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)